Ready to contact us for a consultation about your condition and our medical services? The staff of our Global Patient Services is ready to help. Please select the appropriate button to get started.

New Hope for Lung Disease Patients: Ayelet’s Story

LibAirty Airway Clearance System is the latest device that help stabilize patients battling lung disease.
For Ayelet, who suffers from cystic fibrosis, a crucial part of her daily routine was daily airway clearance. When she had to travel to the US for a lung and liver transplant, it was clear this routine could not be maintained during the six-month wait until a matching donor was found, putting her life at risk.

Synchrony Medical’s LibAirty, developed in collaboration with Sheba pulmonologists, is an airway clearance system in clinical development designed to enable patients with chronic lung disease to receive high-quality respiratory therapy in the privacy of their homes. Recently, LibAirty helped save the life of Ayelet, a 38-year-old cystic fibrosis patient who traveled from Israel to the U.S., where she waited for six months to receive a dual organ transplant. 

Suffering from cystic fibrosis since childhood, when Ayelet’s condition started to deteriorate dramatically, she was referred for a lung and liver transplant in the US. Throughout Ayelet’s life, a crucial part of her care routine was daily airway clearance, assisted by the same respiratory therapist during the five years leading up to the double transplant referral.

When the time came to travel, it was unclear how she would cope without ongoing treatment by her therapist while waiting for a matching donor in the US.

The risk was significant, as Ayelet had rapidly deteriorated in the past when timely airway clearance therapy wasn’t administered on time. Concerns were also raised due to a previous experience with another patient who had traveled abroad for a transplant and did not survive the waiting period. 

In an effort to improve Ayelet’s chances of survival, she was given a prototype of the LibAirty Airway Clearance System, which employs a unique treatment approach based on similar techniques she had regularly performed with her respiratory therapist. Thankfully, the system functioned well, and the device enabled Ayelet to maintain her routine treatment, making it through the waiting period and undergoing the dual transplant successfully.

Ayelet’s story was presented at the 2022 North American Cystic Fibrosis Conference titled ‘A Novel Airway Clearance Device as a Bridge to Double Organ Transplantation,’ delivered by Dr. Moshe Ashkenazi, co-founder of Synchrony Medical and Deputy Director at Sheba’s Edmond and Lily Safra Children’s Hospital. 

“Ayelet is alive and well today,” said Dr. Ashkenazi. “We are very proud to have been there for her when she needed this support the most and now know that LibAirty has the potential to help millions of patients who need airway clearance.”

Sheba Leverages ChatGPT
Accelerating Diagnostics: ChatGPT Results Aligned with Breast Cancer Board Recommendations
Recently, several distinguished Sheba clinicians were impressed by the tool’s capabilities. The group, which included Dr. Vera Sorin, Dr. Eyal Klang, Dr. Miri Sklair-Levy, Prof.…
Read More
Sheba and Vidac
Novel Drug Set to Improve CAR T-Cell Therapy Effectiveness
While many medical centers around the world depend on external labs to genetically engineer patient T-cells, a process that can take up to a few…
Read More
Sheba Named Global Oncology Leader
by Newsweek Magazine
Dedicated to providing those in need across the globe ‘Hope Without Boundaries,’ Sheba treats patients from more than 100 countries each year, employing the latest…
Read More